Hogle William P, Quinn Annette E, Heron Dwight E
Clin J Oncol Nurs. 2003 May-Jun;7(3):324-8. doi: 10.1188/03.CJON.324-328.
Advances in breast brachytherapy techniques have led to the development of new approaches for treatment of patients with early-stage breast cancer. This article reviews the indications, clinical utility, and nursing interventions for the Mammosite Radiation Therapy System (Proxima Therapeutics, Alpharetta, GA) and INTRABEAM (Photoelectron Corporation, North Billerica, MA) radiation therapy system. Each uses a slightly different approach to provide definitive radiotherapy to the breast tumor bed following excision. Radiation oncology nurses should have an understanding of how each system works to provide optimal care as it pertains to education, side effect management, and catheter care for patients receiving each of these types of radiotherapy. These innovative alternatives will greatly reduce required treatment time if clinical studies find them to be equivocal or superior to traditional radiation therapy techniques. These treatment approaches also may make radiation treatments more convenient for women with early-stage breast cancer.
乳腺近距离放射治疗技术的进步促使了早期乳腺癌患者治疗新方法的发展。本文回顾了Mammosite放射治疗系统（Proxima Therapeutics公司，佐治亚州阿尔法利塔）和INTRABEAM放射治疗系统（光电子公司，马萨诸塞州北比勒里卡）的适应症、临床应用及护理干预措施。二者在切除术后为乳腺肿瘤床提供根治性放射治疗时采用的方法略有不同。放射肿瘤学护士应了解每个系统的工作原理，以便在对接受此类放射治疗的患者进行教育、副作用管理及导管护理时提供最佳护理。如果临床研究发现这些创新方法与传统放射治疗技术等效或更优，那么它们将大大缩短所需的治疗时间。这些治疗方法也可能会让早期乳腺癌女性的放射治疗更加便利。
